|
ZFP14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.025400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.609840E-01 |
| Normal-vs-Stage2 |
9.121000E-01 |
| Normal-vs-Stage3 |
2.668000E-02 |
| Normal-vs-Stage4 |
6.837800E-03 |
| Stage1-vs-Stage2 |
5.519400E-01 |
| Stage1-vs-Stage3 |
2.831600E-04 |
| Stage1-vs-Stage4 |
1.78293999999468E-05 |
| Stage2-vs-Stage3 |
1.845810E-01 |
| Stage2-vs-Stage4 |
1.073000E-01 |
| Stage3-vs-Stage4 |
6.167800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.791800E-01 |
| Normal-vs-AfricanAmerican |
2.198600E-01 |
| Normal-vs-Asian |
6.027900E-02 |
| Caucasian-vs-AfricanAmerican |
2.605600E-01 |
| Caucasian-vs-Asian |
1.533370E-01 |
| AfricanAmerican-vs-Asian |
7.021700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.055200E-01 |
| Normal-vs-Female |
9.573800E-01 |
| Male-vs-Female |
6.307800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.466800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.532400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.445800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.394400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.979050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.769800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.686400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.273700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.706400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.865830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.204900E-03 |
| Normal-vs-Grade 2 |
6.306200E-02 |
| Normal-vs-Grade 3 |
1.088810E-01 |
| Normal-vs-Grade 4 |
4.08280000000483E-05 |
| Grade 1-vs-Grade 2 |
2.000400E-01 |
| Grade 1-vs-Grade 3 |
8.005300E-04 |
| Grade 1-vs-Grade 4 |
2.94999999994605E-06 |
| Grade 2-vs-Grade 3 |
1.815830E-04 |
| Grade 2-vs-Grade 4 |
4.8617000425466E-09 |
| Grade 3-vs-Grade 4 |
1.221460E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.276700E-03 |
| Normal-vs-ccB subtype |
1.346120E-02 |
| ccA subtype-vs-ccB subtype |
1.55299999526903E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.659200E-01 |
| Normal-vs-N1 |
1.460000E-03 |
| N0-vs-N1 |
4.963700E-03 |
|
|
